...
首页> 外文期刊>Journal of Medicinal Chemistry >Role of Tyr(356(7.43)) and Ser(190(4.57)) in antagonist binding in the rat beta(1)-adrenergic receptor
【24h】

Role of Tyr(356(7.43)) and Ser(190(4.57)) in antagonist binding in the rat beta(1)-adrenergic receptor

机译:Tyr(356(7.43))和Ser(190(4.57))在大鼠β(1)-肾上腺素受体拮抗剂结合中的作用

获取原文
获取原文并翻译 | 示例

摘要

Site-directed mutagenesis and photoaffinity labeling experiments suggest the existence of at least two distinct binding orientations for aryloxypropanolamine competitive antagonists in the beta-adrenergic receptor (beta-AR), one where the aryloxy moiety is located near transmembrane alpha-helix 7 ( tm 7) and another where it is near tm 5. To explore a hydrophobic pocket involving tms 1, 2, 3, and 7 for potential aryloxy interaction sites, we selected Tyr(356)( (7.43)) and Trp(134)( (3.28)) in the rat beta 1-AR for site-directed mutagenesis studies. Ser(190)( (4.57)) was also investigated, as the equivalent residues are known antagonist interaction sites in the muscarinic M-1 and the dopamine D-2 receptors. Binding affinities ( pK(i)) of a series of structurally diverse aryloxypropanolamine competitive antagonists were determined for wild type and Y356A, Y356F, W134A, and S190A mutant rat beta 1-ARs stably expressed in Chinese hamster ovary cells. To visualize possible antagonist/receptor interactions, the compounds were docked into a three-dimensional model of the wild-type rat beta 1-AR. The results indicate that Tyr356( 7.43) is an important aromatic interaction site for five of the eight competitive antagonists studied, whereas none of the compounds appeared to interact directly with Trp134( 3.28). Only two of the competitive antagonists interacted with Ser(190)( (4.57)) on tm 4. Overall, the results extend our understanding of how beta 1-AR competitive antagonists bind to the hydrophobic pocket involving tms 1, 2, 3, and 7; highlight the importance of Tyr(356)( (7.43)) in this binding pocket; and demonstrate the involvement of tm 4 in competitive antagonist binding.
机译:定点诱变和光亲和标记实验表明,在β-肾上腺素能受体(β-AR)中存在芳氧基丙醇胺竞争性拮抗剂的至少两个不同的结合方向,其中芳氧基部分位于跨膜α-螺旋7(tm 7 )和另一个靠近tm 5的位置。要探索涉及tms 1、2、3和7的疏水性口袋中潜在的芳氧基相互作用位点,我们选择了Tyr(356)((7.43))和Trp(134)((3.28) ))在大鼠beta 1-AR中进行定点诱变研究。还研究了Ser(190)((4.57)),因为等效残基是毒蕈碱M-1和多巴胺D-2受体中已知的拮抗剂相互作用位点。确定了一系列结构不同的芳氧基丙醇胺竞争性拮抗剂的结合亲和力(pK(i))对野生型和在中国仓鼠卵巢细胞中稳定表达的Y356A,Y356F,W134A和S190A突变大鼠β1-AR的结合亲和力。为了可视化可能的拮抗剂/受体相互作用,将化合物对接至野生型大鼠β1-AR的三维模型中。结果表明,对于研究的八种竞争性拮抗剂中的五种,Tyr356(7.43)是重要的芳香相互作用位点,而这些化合物似乎都没有与Trp134(3.28)直接相互作用。仅两种竞争性拮抗剂在tm 4上与Ser(190)((4.57))相互作用。总的来说,结果扩展了我们对β1-AR竞争性拮抗剂如何结合涉及tms 1、2、3和tm的疏水口袋的理解。 7;强调Tyr(356)((7.43))在此装订袋中的重要性;并证明tm 4参与竞争性拮抗剂结合。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号